QQ客服 官方微博 反馈留言

	In Patients With Low- to Intermediate-Risk Thyroid Cancer, a Preablative Thyrotropin Level of 30 μIU/mL Is Not Adequate to Achieve Better Response to 131I Therapy
	Zhao Teng; Liang Jun; Guo Zhenqing; Li Tianjun; Lin Yansong
	2016
卷号	41期号:6页码:454-8
ISSN号	1536-0229
DOI	10.1097/RLU.0000000000001167
URL标识	查看原文
收录类别	PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6376167
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Zhao Teng,Liang Jun,Guo Zhenqing,et al. In Patients With Low- to Intermediate-Risk Thyroid Cancer, a Preablative Thyrotropin Level of 30 μIU/mL Is Not Adequate to Achieve Better Response to 131I Therapy[J],2016,41(6):454-8.
APA	Zhao Teng,Liang Jun,Guo Zhenqing,Li Tianjun,&Lin Yansong.(2016).In Patients With Low- to Intermediate-Risk Thyroid Cancer, a Preablative Thyrotropin Level of 30 μIU/mL Is Not Adequate to Achieve Better Response to 131I Therapy.,41(6),454-8.
MLA	Zhao Teng,et al."In Patients With Low- to Intermediate-Risk Thyroid Cancer, a Preablative Thyrotropin Level of 30 μIU/mL Is Not Adequate to Achieve Better Response to 131I Therapy".41.6(2016):454-8.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。